schizandrin b has been researched along with Bowel Diseases, Inflammatory in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, J; Hu, S; Lin, X; Liu, J; Ma, Z; Shen, Y; Wang, J; Xu, G; Zhao, W; Zhou, J | 1 |
| Chen, H; Liu, W; Liu, Y; Lu, Q; Wang, Z; Yu, T | 1 |
2 other study(ies) available for schizandrin b and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Schisandrin B-mediated TH17 cell differentiation attenuates bowel inflammation.
Topics: Animals; Anti-Inflammatory Agents; Cell Differentiation; Cells, Cultured; Cyclooctanes; Female; Humans; Inflammatory Bowel Diseases; Lignans; Mice, Inbred C57BL; Polycyclic Compounds; Th17 Cells | 2021 |
Suppression of MAPK and NF-κ B pathways by schisandrin B contributes to attenuation of DSS-induced mice model of inflammatory bowel disease.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colon; Cyclooctanes; Cytokines; Dextran Sulfate; Female; Inflammatory Bowel Diseases; Lignans; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Polycyclic Compounds; Signal Transduction | 2015 |